AK119 drug page Clinical trials

Trials with AK119

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
1Recruiting
1Countries
257Planned patients

Showing 1–2 of 2

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Recruiting Phase 1 87 patients NCT05689853

This is a Phase Ib/II study to assess the safety, tolerability and preliminary efficacy of AK119 combined with AK112 in patients with advanced solid tumors.

China Apr 2023 – Jun 2027 Interventional
Combined with: AK112
A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
Ongoing, not recruiting Phase 1 170 patients NCT05846867

This is an open label, multicenter Phase Ib/II clinical study on the efficacy and safety of AK119 and AK112 in combination with or without chemotherapy, and AK112 monotherapy in pMMR/MSS CRC

China May 2023 – Aug 2026 Interventional

Where the recruiting trials are